Brief: Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
15/05/2023 12:17
May 15 (Reuters) - Fulcrum Therapeutics Inc FULC.O :
* FULCRUM THERAPEUTICS APPOINTS ALEX C. SAPIR CHIEF
EXECUTIVE
OFFICER
* FULCRUM THERAPEUTICS - INTERIM CEO AND PRESIDENT, ROBERT
GOULD
WILL CONTINUE TO SERVE AS MEMBER OF BOARD OF DIRECTORS
FOLLOWING TRANSITION
Source text for Eikon: ID:nGNXDmmtB
Further company coverage: FULC.O
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback